EUVIMEDEUVIMED entdecken
Leserbrief

Making Pharmaceutical Administration Evidence Cumulative: What PBPK Teaches Us About Building Knowledge Across Products

Carlos Victor Montefusco-Pereira, Howard Lopes Ribeiro Junior

European Journal of Pharmaceutics and Biopharmaceutics · 2026

DOI: 10.1016/j.ejpb.2026.115200 ↗

Kurz gefasst

Leserbrief in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2026. Verfasst von Carlos Victor Montefusco-Pereira und 1 weiteren Autor:innen. Beteiligte Einrichtung: Independent Researcher in Data Science and Artificial Intelligence in Industrial Pharmaceutics, Berlin, Germany. Electronic address: cmontefusco@gmai…. Hauptthemen laut MEDLINE: Models, Biological. Die Arbeit nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pharmaceutical administration studies determine whether a medicine can be prepared, held, and delivered without unacceptable loss of quality. Their conclusions are essential to product instructions, yet the underlying evidence is difficult to use beyond the product and conditions originally tested. This letter contrasts that pattern with physiologically based pharmacokinetic modelling, a field in which system, drug, and study information are represented separately and the purpose and limits of model use are made explicit. Administration science does not require a PBPK model. It does, however, need records that preserve the relationships among product and formulation attributes, administration-system components, preparation and use conditions, measured outcomes, and the boundaries of the experiment. Standardized, structured records would not remove the need for product-specific studies. They would make previous work easier to interpret, reveal when further testing is necessary, and allow administration evidence to contribute to cumulative pharmaceutical knowledge.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Models, BiologicalHumansChemistry, PharmaceuticalPharmaceutical PreparationsPharmacokinetics

Stichwörter der Autor:innen

CompatibilityIn-use stabilityKnowledge managementPBPKPharmaceutical administration

Substanzen

Pharmaceutical Preparations

Autor:innen und Institutionen

  • Independent Researcher in Data Science and Artificial Intelligence in Industrial Pharmaceutics, Berlin, Germany. Electronic address: cmontefusco@gmail.com.
  • Center for Research and Drug Development (NPDM), Federal University of Ceará, Fortaleza 60430-275, Brazil; PostGraduate Program in Pathology, Federal University of Ceará, Fortaleza, Brazil; Post-Graduate Program in Tran…

Zitieren

APA

Montefusco-Pereira, C. V., & Ribeiro Junior, H. L. (2026). Making Pharmaceutical Administration Evidence Cumulative: What PBPK Teaches Us About Building Knowledge Across Products. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2026.115200

Vancouver

Montefusco-Pereira CV, Ribeiro Junior HL. Making Pharmaceutical Administration Evidence Cumulative: What PBPK Teaches Us About Building Knowledge Across Products. European Journal of Pharmaceutics and Biopharmaceutics. 2026. doi:10.1016/j.ejpb.2026.115200

BibTeX
@article{MontefuscoPereira2026,
  author = {Montefusco-Pereira, Carlos Victor and Ribeiro Junior, Howard Lopes},
  title = {Making Pharmaceutical Administration Evidence Cumulative: What PBPK Teaches Us About Building Knowledge Across Products},
  journal = {European Journal of Pharmaceutics and Biopharmaceutics},
  year = {2026},
  doi = {10.1016/j.ejpb.2026.115200}
}
Kostenlos starten →